Background Patients with type 2 diabetes mellitus (T2DM) have higher pancreatic cancer (PC) risk. While aspirin has chemopreventive effects on digestive cancers, its effect on PC among patients with ...

UC San Diego’s latest study reveals MICAL2 as a critical factor in pancreatic cancer progression, offering new avenues for treatment through targeted therapies that could inhibit this enzyme and slow ...